reference/8600682

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8600682

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	444
issn	1470-2045
issueIdentifier	5
pageRange	435-444
publicationName	The Lancet. Oncology
startingPage	435
bibliographicCitation	Pfreundschuh M, Ho AD, Cavallin-Stahl E, Wolf M, Pettengell R, Vasova I, Belch A, Walewski J, Zinzani PL, Mingrone W, Kvaloy S, Shpilberg O, Jaeger U, Hansen M, Corrado C, Scheliga A, Loeffler M, Kuhnt E; MabThera International Trial (MInT) Group. Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study. Lancet Oncol. 2008 May;9(5):435–44. doi: 10.1016/s1470-2045(08)70078-0. PMID: 18400558.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12a9aebdfbb691441266d0b4748a86a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_457b7cfb552565b72751c6dce52071e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8bd940f6f382fe7032f46aca1bbafae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2c2fb3edd91c22cd652e7ce41918cae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa1afaa0e005acfd5df23d361694adba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21a812529b110897c13b76285871ed99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cc9815c2505baf01b5d9b444a93b1aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d9ebc4aea7af3c81f4b0462767167a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4724bcf07d49cd3a80c65d3805c9f8bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b16da8806df165bafdf2e52cf9b382eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14c6c3331300c49c31016f4f82d20ac1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c3cdf30a908b975b55fa00ebc0e563b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e9cae2dc7e2e9e0d8122f7a169853bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_baf8b9ffdc8fc312f8e0b9aa3def0d59 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e9ab0da0a1cb7ad207b682675718d07 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6530-5855 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_deb05e311c9d1e7d6f6462e8dc60c5cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a44ffd65b79bf79b0847367d5395c02d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8d49150be7e9a2e918346124609e79f
date	200805
identifier	https://doi.org/10.1016/s1470-2045%2808%2970078-0 https://pubmed.ncbi.nlm.nih.gov/18400558
isPartOf	https://portal.issn.org/resource/ISSN/1470-2045 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27004
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
discusses	http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0544940 http://id.nlm.nih.gov/mesh/M0006784
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D018579 http://id.nlm.nih.gov/mesh/D016403Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D058846 http://id.nlm.nih.gov/mesh/D014750Q000008 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D018714 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D016403Q000401 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000069283 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D016016 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D016403Q000473 http://id.nlm.nih.gov/mesh/D016403Q000532 http://id.nlm.nih.gov/mesh/D011379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9859 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 82.